Accelerate Diagnostics
AXDX
AXDX was delisted on the 14th of May, 2025.
97 hedge funds and large institutions have $401M invested in Accelerate Diagnostics in 2015 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 39 increasing their positions, 15 reducing their positions, and 11 closing their positions.
160% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 15
100% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 11
59% more capital invested
Capital invested by funds: $252M → $401M (+$149M)
10% more funds holding
Funds holding: 88 → 97 (+9)
12% less call options, than puts
Call options by funds: $3.03M | Put options by funds: $3.46M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$2.16M |
| 2 |
RCM
Raging Capital Management
Rocky Hill,
New Jersey
|
-$1.41M |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$1.13M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$606K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$518K |
AXDX Hedge Fund Activity: Q4 2015 in Review
97 of the 3,811 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q4 2015, worth a combined $401M — up 59% from $252M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new AXDX positions and 11 closed out — a net gain of 11 holders — while 39 added to existing stakes and 15 trimmed.
The largest buyer was Miura Global Management, adding an estimated $16.4M. The largest seller was Millennium Management, cutting an estimated $2.16M.
- 97 institutional investors held Accelerate Diagnostics (AXDX) as of Q4 2015, up from 88 in Q3 2015.
- Funds reported $401M of Accelerate Diagnostics stock for Q4 2015, up 59% quarter-over-quarter.
- 22 funds opened new Accelerate Diagnostics positions in Q4 2015 and 11 closed out, a net change of +11 holders.
- The largest Accelerate Diagnostics buyer in Q4 2015 was Miura Global Management, an estimated $16.4M added.
- The largest Accelerate Diagnostics seller in Q4 2015 was Millennium Management, an estimated $2.16M sold.
Based on aggregated 13F filings for Q4 2015.